 |
Trimetrexate glucuronate |
|---|---|
| Trade Name | |
| Orphan Indication | Metastatic carcinoma of the head and neck (i.e. buccal cavity, pharynx, and larynx). |
| USA Market Approval | USA |
| USA Designation Date | 1985-07-25 00:00:00 |
| Sponsor | Medimmune Oncology, Inc.;One MedImmune Way;Gaithersburg, MD, 20878 |
